Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Rose hip exerts antidiabetic effects via a mechanism involving downregulation of the hepatic lipogenic program

Axling, Ulrika LU ; Henriksson, Emma LU ; Ström, Kristoffer LU ; Alenfall, Jan ; Göransson, Olga LU orcid and Holm, Cecilia LU (2011) In American Journal of Physiology: Endocrinology and Metabolism 300(1). p.111-121
Abstract
Andersson U, Henriksson E, Strom K, Alenfall J, Goransson O, Holm C. Rose hip exerts antidiabetic effects via a mechanism involving downregulation of the hepatic lipogenic program. Am J Physiol Endocrinol Metab 300: E111-E121, 2011. First published October 19, 2010; doi:10.1152/ajpendo.00268.2010.-The aim of this study was to investigate the metabolic effects of a dietary supplement of powdered rose hip to C57BL/6J mice fed a high-fat diet (HFD). Two different study protocols were used; rose hip was fed together with HFD to lean mice for 20 wk (prevention study) and to obese mice for 10 wk (intervention study). Parameters related to obesity and glucose tolerance were monitored, and livers were examined for lipids and expression of genes... (More)
Andersson U, Henriksson E, Strom K, Alenfall J, Goransson O, Holm C. Rose hip exerts antidiabetic effects via a mechanism involving downregulation of the hepatic lipogenic program. Am J Physiol Endocrinol Metab 300: E111-E121, 2011. First published October 19, 2010; doi:10.1152/ajpendo.00268.2010.-The aim of this study was to investigate the metabolic effects of a dietary supplement of powdered rose hip to C57BL/6J mice fed a high-fat diet (HFD). Two different study protocols were used; rose hip was fed together with HFD to lean mice for 20 wk (prevention study) and to obese mice for 10 wk (intervention study). Parameters related to obesity and glucose tolerance were monitored, and livers were examined for lipids and expression of genes and proteins related to lipid metabolism and gluconeogenesis. A supplement of rose hip was capable of both preventing and reversing the increase in body weight and body fat mass imposed by a HFD in the C57BL/6J mouse. Oral and intravenous glucose tolerance tests together with lower basal levels of insulin and glucose showed improved glucose tolerance in mice fed a supplement of rose hip compared with control mice. Hepatic lipid accumulation was reduced in mice fed rose hip compared with control, and the expression of lipogenic proteins was downregulated, whereas AMP-activated protein kinase and other proteins involved in fatty acid oxidation were unaltered. Rose hip intake lowered total plasma cholesterol as well as the low-density lipoprotein-to-high-density lipoprotein ratio via a mechanism not involving altered gene expression of sterol regulatory element-binding protein 2 or 3-hydroxymethylglutaryl-CoA reductase. Taken together, these data show that a dietary supplement of rose hip prevents the development of a diabetic state in the C57BL/6J mouse and that downregulation of the hepatic lipogenic program appears to be at least one mechanism underlying the antidiabetic effect of rose hip. (Less)
Please use this url to cite or link to this publication:
author
; ; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
glucose tolerance, cholesterol, polyphenol
in
American Journal of Physiology: Endocrinology and Metabolism
volume
300
issue
1
pages
111 - 121
publisher
American Physiological Society
external identifiers
  • wos:000285711200014
  • scopus:78650800873
  • pmid:20959531
ISSN
1522-1555
DOI
10.1152/ajpendo.00268.2010
project
ANTIDIABETIC FOOD CENTRE
language
English
LU publication?
yes
additional info
The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Insulin Signal Transduction (013212014), Molecular Endocrinology (013212018), Diabetes, Metabolism and Endocrinology (LUR000004)
id
04d63a78-71c6-4c71-8146-51475b0f4050 (old id 1791058)
date added to LUP
2016-04-01 13:06:31
date last changed
2024-01-24 05:40:27
@article{04d63a78-71c6-4c71-8146-51475b0f4050,
  abstract     = {{Andersson U, Henriksson E, Strom K, Alenfall J, Goransson O, Holm C. Rose hip exerts antidiabetic effects via a mechanism involving downregulation of the hepatic lipogenic program. Am J Physiol Endocrinol Metab 300: E111-E121, 2011. First published October 19, 2010; doi:10.1152/ajpendo.00268.2010.-The aim of this study was to investigate the metabolic effects of a dietary supplement of powdered rose hip to C57BL/6J mice fed a high-fat diet (HFD). Two different study protocols were used; rose hip was fed together with HFD to lean mice for 20 wk (prevention study) and to obese mice for 10 wk (intervention study). Parameters related to obesity and glucose tolerance were monitored, and livers were examined for lipids and expression of genes and proteins related to lipid metabolism and gluconeogenesis. A supplement of rose hip was capable of both preventing and reversing the increase in body weight and body fat mass imposed by a HFD in the C57BL/6J mouse. Oral and intravenous glucose tolerance tests together with lower basal levels of insulin and glucose showed improved glucose tolerance in mice fed a supplement of rose hip compared with control mice. Hepatic lipid accumulation was reduced in mice fed rose hip compared with control, and the expression of lipogenic proteins was downregulated, whereas AMP-activated protein kinase and other proteins involved in fatty acid oxidation were unaltered. Rose hip intake lowered total plasma cholesterol as well as the low-density lipoprotein-to-high-density lipoprotein ratio via a mechanism not involving altered gene expression of sterol regulatory element-binding protein 2 or 3-hydroxymethylglutaryl-CoA reductase. Taken together, these data show that a dietary supplement of rose hip prevents the development of a diabetic state in the C57BL/6J mouse and that downregulation of the hepatic lipogenic program appears to be at least one mechanism underlying the antidiabetic effect of rose hip.}},
  author       = {{Axling, Ulrika and Henriksson, Emma and Ström, Kristoffer and Alenfall, Jan and Göransson, Olga and Holm, Cecilia}},
  issn         = {{1522-1555}},
  keywords     = {{glucose tolerance; cholesterol; polyphenol}},
  language     = {{eng}},
  number       = {{1}},
  pages        = {{111--121}},
  publisher    = {{American Physiological Society}},
  series       = {{American Journal of Physiology: Endocrinology and Metabolism}},
  title        = {{Rose hip exerts antidiabetic effects via a mechanism involving downregulation of the hepatic lipogenic program}},
  url          = {{http://dx.doi.org/10.1152/ajpendo.00268.2010}},
  doi          = {{10.1152/ajpendo.00268.2010}},
  volume       = {{300}},
  year         = {{2011}},
}